Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $7.98 -0.42 (-4.95%) As of 10:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.66Holdings in PILL have an aggregate rating of Moderate Buy based on 256 analyst ratings issued in the past year covering 21 companies (40.8% of the portfolio).PILL Aggregate Price Target$8.39High Prediction$8.39Average Prediction$8.39Low Prediction$8.39Holdings in PILL have an aggregate price target of $8.39 and a range of $8.39 to $8.39 covering 21 companies (40.8% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.26%CORTCorcept Therapeutics$77.77-12.0%4.9121 of 5 stars2.57$135.25 73.9%7Analyst ForecastInsider Trade2.00%HROWHarrow$39.78-1.9%2.8338 of 5 stars2.67$68.50 72.2%9Analyst Forecast1.99%LGNDLigand Pharmaceuticals$180.58-1.0%3.9525 of 5 stars2.71$176.50 -2.3%7News CoverageAnalyst Forecast1.99%CRNXCrinetics Pharmaceuticals$45.25-1.1%3.8682 of 5 stars2.71$74.45 64.5%14Analyst Forecast1.99%TARSTarsus Pharmaceuticals$68.87-2.1%0.6979 of 5 stars2.50$66.67 -3.2%8Positive NewsAnalyst Forecast1.99%OGNOrganon & Co.$9.77-1.5%4.8293 of 5 stars2.50$17.33 77.5%6Analyst Forecast1.98%JAZZJazz Pharmaceuticals$136.45-1.2%4.6078 of 5 stars2.76$178.93 31.1%17Trending NewsAnalyst ForecastAnalyst Revision1.97%SUPNSupernus Pharmaceuticals$48.96-1.1%4.0763 of 5 stars3.00$64.00 30.7%5News CoverageAnalyst ForecastGap Up1.96%ELANElanco Animal Health$20.22+0.7%2.6271 of 5 stars2.91$19.14 -5.3%11Analyst Upgrade1.95%JNJJohnson & Johnson$190.84-0.1%4.6882 of 5 stars2.73$191.41 0.3%22Trending NewsUpcoming EarningsAnalyst Forecast1.94%RPRXRoyalty Pharma$36.140.0%4.8466 of 5 stars3.20$46.00 27.3%5Analyst Upgrade1.92%LLYEli Lilly and Company$860.19+0.6%4.9928 of 5 stars2.64$948.56 10.3%25Trending NewsAnalyst Forecast1.91%PFEPfizer$25.16-0.3%4.959 of 5 stars2.37$28.41 12.9%19Trending NewsDividend AnnouncementAnalyst ForecastOptions Volume1.90%ANIPANI Pharmaceuticals$90.36-0.5%3.8462 of 5 stars2.90$99.14 9.7%10Analyst Downgrade1.88%PBHPrestige Consumer Healthcare$62.24-0.9%4.3519 of 5 stars2.43$94.80 52.3%71.87%HRMYHarmony Biosciences$26.23-2.1%4.6421 of 5 stars2.90$46.11 75.8%101.85%AXSMAxsome Therapeutics$121.64-0.7%4.7213 of 5 stars3.00$177.93 46.3%17Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.85%BMYBristol Myers Squibb$44.14-1.2%4.9842 of 5 stars2.33$57.14 29.5%21Positive News1.85%MRKMerck & Co., Inc.$87.61+0.1%4.9942 of 5 stars2.29$104.31 19.1%21Trending NewsAnalyst ForecastAnalyst Revision1.85%PRGOPerrigo$21.59+0.2%4.9172 of 5 stars2.20$34.00 57.5%5News CoveragePositive NewsAnalyst Forecast1.85%ZTSZoetis$142.27-0.8%4.8566 of 5 stars2.50$200.88 41.2%10Positive NewsDividend AnnouncementAnalyst Forecast This page (NYSEARCA:PILL) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
